Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03195270 · ClinicalTrials.gov registry record · Phase 1
Use of PET/MR Imaging in Chronic Pain
A Phase 1 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 1
- Development phase
- 88
- Enrollment target
NCT03195270: Completed Phase 1 study, sponsored by Stanford University.
NCT03195270 is a Phase 1 study that has completed, run by Stanford University. The registered enrollment target is 88 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03195270, a Phase 1 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 88 participants
- Enrollment target
Study Summary
The investigators are studying the ability of PET/MR imaging (using the PET tracer \[18F\]FDG) to objectively identify and characterize pain generators in patients suffering from chronic pain.
Interventions
- DEVICE PET/MRI
- DRUG [18F]FDG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2014-11-24 |
| Est. Completion | 2022-01-20 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03195270
The ClinicalTrials.gov registry entry for NCT03195270 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PET/MRI is the first listed.
NCT03195270 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03195270 about?
NCT03195270 is a clinical study titled "Use of PET/MR Imaging in Chronic Pain". The investigators are studying the ability of PET/MR imaging (using the PET tracer \[18F\]FDG) to objectively identify and characterize pain generators in patients suffering from chronic pain.
What is the current status of trial NCT03195270?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 88 participants. The study started on 2014-11-24. Estimated completion is 2022-01-20.
What interventions are being tested in trial NCT03195270?
The interventions under investigation include: PET/MRI (DEVICE), [18F]FDG (DRUG).
Who is sponsoring clinical trial NCT03195270?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.